Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a biotechnology company dedicated to the advancement of regenerative therapeutics in the fields of immunotherapy, ...

FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT ...

Notably, the exercise price represented a 24.9% premium to VCI Global's closing market price of $4.50 on June 24, 2026, reflecting institutional confidence in the Company's strategic transformation, ...

Zee Entertainment plans to issue ₹3,143 crore in warrants to promoters, requiring 25% upfront payment for conversion.

An announcement from East Star Resources ( (GB:EST)) is now available. East Star Resources has confirmed the admission of 446,538 new ordinary shares to trading on the London Stock Exchange’s Main ...

BROSSARD, Quebec, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (ADK:CA) (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health ...

BRISBANE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell ...

Occidental offers warrant holders a temporary reduced exercise price of $21.30 for their shares until March 31, 2025. Occidental announced an offer to exercise its publicly traded warrants at a ...

BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (ADK:CA) (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health ...

Moleculin Biotech Inc (NASDAQ:MBRX) saw its stock tumble 34.3% in premarket trading Thursday after announcing agreements with certain warrant holders to immediately exercise existing warrants. Under ...

BROSSARD, Quebec, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues ...